EFFICACY AND SAFETY OF ONCE-DAILY AND TWICE-DAILY OLOPATADINE/MOMETASONE NASAL SPRAY TREATMENT IN SEASONAL ALLERGIC RHINITIS

被引:0
|
作者
Andrews, C.
Mohar, D.
Agarwal, P.
Salhi, Y.
Tantry, S.
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
P433
引用
收藏
页码:S89 / S90
页数:2
相关论文
共 50 条
  • [41] Efficacy and safety of the combination nasal spray olopatadine hydrochloride-mometasone furoate in the treatment of allergic rhinitis
    Klimek L.
    Klimek F.
    Bergmann C.
    Hagemann J.
    Cuevas M.
    Becker S.
    Allergo Journal International, 2024, 33 (1) : 9 - 19
  • [42] BUDESONIDE ONCE-DAILY IN SEASONAL ALLERGIC RHINITIS
    ROSS, JRM
    MOHAN, G
    ANDERSSON, B
    TAYLOR, MD
    RICHARDSON, PDI
    CURRENT MEDICAL RESEARCH AND OPINION, 1991, 12 (08) : 507 - 515
  • [43] Efficacy and Safety of the Combination Nasal Spray Olopatadine Hydrochloride-Mometasone Furoate in the Treatment of allergic Rhinitis
    Klimek, L.
    Klimek, F.
    Bergmann, C.
    Hagemann, J.
    Cuevas, M.
    Becker, S.
    ALLERGOLOGIE, 2024, 47 (04)
  • [44] Efficacy and safety of once-daily triamcinolone acetonide aqueous nasal spray in pediatric patients with spring grass seasonal allergic rhinitis.
    Smith, JA
    Schenkel, EJ
    Gross, G
    Jacobson, K
    Kobayashi, R
    Settipane, G
    Feiss, G
    Furst, JA
    Simpson, B
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (01) : 60 - 60
  • [45] EFFICACY AND SAFETY OF ONCE-DAILY INDACATEROL/MOMETASONE COMPARED WITH TWICE-DAILY SALMETEROL/FLUTICASONE IN PATIENTS WITH MODERATE TO VERY SEVERE COPD
    Kirsten, Anne-Maria
    Richard, Alexia
    Tanase, Ana-Maria
    Cao Weihua
    Hosoe, Motoi
    Hederer, Bettina
    THORAX, 2014, 69 : A187 - A187
  • [46] COMPARISON OF THE EFFICACY AND SAFETY OF ONCE-DAILY VERSUS TWICE-DAILY FORMULATIONS OF DILTIAZEM IN THE TREATMENT OF SYSTEMIC HYPERTENSION
    RUDDY, TD
    WRIGHT, JM
    SAVARD, D
    HANDA, SP
    CHOCKALINGAM, A
    BOULET, AP
    CARDIOVASCULAR DRUGS AND THERAPY, 1995, 9 (03) : 413 - 420
  • [47] Efficacy and safety of once-daily and twice-daily clarithromycin formulations in the treatment of acute exacerbations of chronic bronchitis
    Vetter, N
    Argryopoulou-Pataka, P
    Droszcz, W
    Estruch-Riba, R
    Thomas, P
    MacLeod, CM
    ADVANCES IN THERAPY, 1999, 16 (01) : 13 - 21
  • [48] LACK OF HYPOTHALAMIC-PITUITARY-ADRENAL AXIS SUPPRESSION WITH ONCE-DAILY OR TWICE-DAILY BECLOMETHASONE DIPROPIONATE AQUEOUS NASAL SPRAY ADMINISTERED TO PATIENTS WITH ALLERGIC RHINITIS
    BRANNAN, MD
    HERRON, JM
    REIDENBERG, P
    AFFRIME, MB
    CLINICAL THERAPEUTICS, 1995, 17 (04) : 637 - 647
  • [49] LITHIUM TREATMENT - A COMPARISON OF ONCE-DAILY AND TWICE-DAILY DOSING
    ABRAHAM, G
    DELVA, N
    WALDRON, J
    LAWSON, JS
    OWEN, J
    ACTA PSYCHIATRICA SCANDINAVICA, 1992, 85 (01) : 65 - 69
  • [50] Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children
    Brannan, MD
    Herron, JM
    Affrime, MB
    CLINICAL THERAPEUTICS, 1997, 19 (06) : 1330 - 1339